Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tatjana Pavicic, Welf Prager, Markus Klöppel, Simon Ravichandran & Olivier Galatoire. (2015) IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study. Clinical, Cosmetic and Investigational Dermatology 8, pages 135-142.
Read now
Read now
Yana Yutskovskaya, Elena Gubanova, Irina Khrustaleva, Vasiliy Atamanov, Anastasiya Saybel, Elena Parsagashvili, Irina Dmitrieva, Elena Sanchez, Natalia Lapatina, Tatiana Korolkova, Alena Saromytskaya, Elena Goltsova & Elmira Satardinova. (2015) IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations. Clinical, Cosmetic and Investigational Dermatology 8, pages 297-306.
Read now
Read now
Thomas Rappl, Daryousch Parvizi, Herwig Friedl, Maria Wiedner, Simone May, Bettina Kranzelbinder, Paul Wurzer & Bengt Hellbom. (2013) Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study. Clinical, Cosmetic and Investigational Dermatology 6, pages 211-219.
Read now
Read now
Articles from other publishers (16)
Isabel Fairmont & Andrew Winkler. (2020) Novel Cosmetic Uses of Botulinum Toxin in the Head and Neck. Current Otorhinolaryngology Reports 8:4, pages 344-350.
Crossref
Crossref
Erin Alouf, Tina Murphy & Gregory Alouf. (2019) Botulinum Toxin Type A: Evaluation of Onset and Satisfaction. Plastic Surgical Nursing 39:4, pages 148-156.
Crossref
Crossref
Wolfgang Funk, Martina Kerscher & Heike Buntrock-Döpke. 2019. Minimalinvasive nichtoperative Methoden in der Gesichtsästhetik. Minimalinvasive nichtoperative Methoden in der Gesichtsästhetik
1
30
.
Sinyoung Song, Yeon Hoon Lee, Joon Pio Hong & Tae Suk Oh. (2018) Safety, efficacy, and onset of a novel botulinum toxin type A (Nabota) for the treatment of glabellar frown lines: a single-arm, prospective, phase 4 clinical study. Archives of Craniofacial Surgery 19:3, pages 168-174.
Crossref
Crossref
Erin Alouf, Tina Murphy & Gregory Alouf. (2018) Botulinum Toxin Type A: Evaluation of Onset and Satisfaction. Plastic Surgical Nursing 38:3, pages 105-113.
Crossref
Crossref
G. Wright, A. Lax & S. B. Mehta. (2018) A review of the longevity of effect of botulinum toxin in wrinkle treatments. British Dental Journal 224:4, pages 255-260.
Crossref
Crossref
Je-Young Park, Nak-Kwan Sung & Jonathan M. Pitt. (2017) Efficacy and Tolerability of IncobotulinumtoxinA for Treating Glabellar Frown Lines in Korean Adults: A Postmarketing Observational Study. Dermatologic Surgery 43:3, pages S304-S311.
Crossref
Crossref
Derek H. Jones, Martina Kerscher, Thorin Geister, Michael A. Hast & Petra Weissenberger. (2017) Efficacy of IncobotulinumtoxinA for the Treatment of Glabellar Frown Lines in Male Subjects: Post-Hoc Analyses From Randomized, Double-Blind Pivotal Studies. Dermatologic Surgery 43:2, pages S235-S241.
Crossref
Crossref
JTE Lim, DK Loh, K Soh & O Sunga. (2017) Efficacy and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines. Singapore Medical Journal 58:10, pages 606-609.
Crossref
Crossref
Ulrich Kühne & Matthias Imhof. 2017. Botulinum Toxins. Botulinum Toxins
79
95
.
José Raúl MontesAnthony J. WilsonBrian L. ChangIvona Percec. (2016) Technical Considerations for Filler and Neuromodulator Refinements. Plastic and Reconstructive Surgery - Global Open 4:12S, pages e1178.
Crossref
Crossref
Brian L. Chang, Anthony J. Wilson, Anthony J. Taglienti, Catherine S. Chang, Nancy Folsom & Ivona Percec. (2016) Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes. Aesthetic Surgery Journal 36:7, pages 810-820.
Crossref
Crossref
Jose Guerrrerosantos, Pulido Galaviz Carlos Eduardo, Josefina Mateos Arriola, Alberto I. Villa Manzano, Benjamin Villarán-Muñoz, Leonel García Benavides & Ma Guadalupe Vazquez. (2015) Effectiveness of Botulinum Toxin (Type-A) Administered by the Fixed-Site Dosing Approach Versus the Muscle Area Identification. Aesthetic Plastic Surgery 39:2, pages 243-251.
Crossref
Crossref
Enrique Garcia-Murray, María Luisa Velasco Villasenor, Berenice Acevedo, Silvia Luna, Jane Lee, Jacob M. Waugh & Carl S. Hornfeldt. (2015) Safety and Efficacy of RT002, an Injectable Botulinum Toxin Type A, for Treating Glabellar Lines. Dermatologic Surgery 41:Supplement 1, pages S47-S55.
Crossref
Crossref
Andrew Dorizas, Nils Krueger & Neil S. Sadick. (2014) Aesthetic Uses of the Botulinum Toxin. Dermatologic Clinics 32:1, pages 23-36.
Crossref
Crossref
Hun-Mu Yang & Hee-Jin Kim. (2013) Anatomical study of the corrugator supercilii muscle and its clinical implication with botulinum toxin A injection. Surgical and Radiologic Anatomy 35:9, pages 817-821.
Crossref
Crossref